The trial, in the experimental phase, will evaluate the safety of the medication in more than a thousand Cuban patients, who must meet various medical criteria and have the help of a physically and mentally trained caregiver to understand and collaborate with the investigation.Research on the drug Neuralcim to care for patients with mild or moderate Alzheimer’s includes several Cuban hospitals; Meanwhile, in Villa Clara the evaluation process transcends the Arnaldo Milián Hospital.If the drug confirms its effectiveness, it will be an achievement for Cuba, where more than 160 thousand people live with dementia, as well as for the rest of the world.
Source: Radio Reloj
Rating
(Votos: 0 Promedio: 0)
Views: 0
